Treatment News : Norvir-Boosted Reyataz Linked to High Kidney Stone Risk

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » September 2012

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


September 4, 2012

Norvir-Boosted Reyataz Linked to High Kidney Stone Risk

People living with HIV using Norvir (ritonavir)-boosted Reyataz (atazanavir) were roughly ten times more likely to experience kidney stones, compared with those using other Norvir-boosted protease inhibitor (PI)-based regimens, according to a review of patient data conducted by Japanese researchers published online ahead of print by Clinical Infectious Diseases. In their analysis of 1,240 people treated with a Norvir-boosted PI regimen between 2004 and 2010, 35 HIV-positive individuals experienced kidney stones—31 (88.5 percent) of whom were using Norvir-boosted Reyataz. The kidney stone incidence rate was 7 percent among those using Norvir-boosted Reyataz, compared with 0.5 percent among those using other Norvir-boosted PI regimens.  Additionally, six of 18 people who continued using Norvir-boosted Reyataz after being diagnosed with kidney stones experienced a recurrence after an average of five months. Norvir-boosted Reyataz “should be carefully prescribed to patients with predisposing factors for renal stone formation or those with chronic kidney disease,” the authors conclude. “For those who developed [Norvir-boosted Reyataz]-induced renal stones, discontinuation of [the regimen] is warranted because of the high risk of recurrence.”

To read the Clinical Infectious Diseases article (paid subscription required), click here.

Search: hiv, kidney stones, neprhrolithiasis, renal stones, atazanavir, reytaz, norvir, ritonavir, japan, tokyo

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (2 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.